FDA Guidance on Discontinuance or Interruption Notification: Specific Aspects
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The new article provides additional details regarding specific aspects associated with remote regulatory assessments.
The article highlights the critical points associated with the existing regulatory framework for remote regulatory assessments.
The new article covers some specific aspects associated with the evidential expectations for implantable devices, such as human factors, clinical performance testing, and labeling.
The article outlines the general considerations for evidentiary expectations and describes in detail the authority’s non-clinical recommendations.
#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET
Register Now